Arrowhead Pharmaceuticals, INC. (ARWR) — DEFA14A Filings
All DEFA14A filings from Arrowhead Pharmaceuticals, INC.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Arrowhead Pharma Files Definitive Additional Proxy Materials
— Feb 27, 2024 Risk: low
ARROWHEAD PHARMACEUTICALS, INC. filed a DEFA14A on February 27, 2024, as definitive additional materials for a proxy statement. The filing indicates that the co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX